Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Nov 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1771567012 | Pseudoscleroderma due to cytotoxic therapy (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1782657019 | Pseudoscleroderma due to cytotoxic therapy | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1787818018 | Pseudoscleroderma due to cytotoxic drug | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1787819014 | Scleroderma-like reaction to cytotoxic drug | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Is a | Dermatosis due to cytotoxic therapy (disorder) | true | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Finding site | Skin structure | true | Inferred relationship | Some | 1 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Causative agent | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Associated morphology | Morphologically abnormal structure (morphologic abnormality) | false | Inferred relationship | Some | 1 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Causative agent | Drug, medicament or biological substance | false | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Causative agent | Drug or medicament (substance) | false | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Causative agent | Drug or medicament (substance) | false | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Causative agent | Antineoplastic agent (substance) | false | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Finding site | Skin structure | false | Inferred relationship | Some | 2 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Associated morphology | Morphologically abnormal structure (morphologic abnormality) | false | Inferred relationship | Some | 1 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Causative agent | Cytotoxic | true | Inferred relationship | Some | 1 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Is a | Scleroderma-like secondary cutaneous sclerosis (disorder) | false | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Due to | Chemotherapy | true | Inferred relationship | Some | 2 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Finding site | Skin structure | false | Inferred relationship | Some | 3 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Associated morphology | Sclerosis | false | Inferred relationship | Some | 3 | |
Pseudoscleroderma due to cytotoxic therapy (disorder) | Is a | Drug-induced pseudoscleroderma (disorder) | true | Inferred relationship | Some | ||
Pseudoscleroderma due to cytotoxic therapy (disorder) | Associated morphology | Sclerosis | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets